Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 101
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
BMC Nephrol ; 24(1): 62, 2023 03 21.
Artigo em Inglês | MEDLINE | ID: mdl-36944928

RESUMO

BACKGROUND: Chronic kidney disease (CKD) is a globally significant non-communicable disorder. CKD prevalence varies between countries and within a country. We compared the prevalence rates of CKD in South Africa with sub-Saharan Africa, Africa, and globally. METHODS: We registered a systematic review with the International Prospective Register of Systematic Reviews for prevalence studies reporting CKD stages III-V from 2013 to 2021. The analysis sought to explain any significant differences in prevalence rates. The R statistical package was used for data analysis. Comparisons included measures of effect size due to the large sample sizes analysed. We also compared sex differences in prevalence rates, common aetiologies, and type of study methodologies employed. RESULTS: Eight studies were analysed, with two from each region. The matched prevalence rates of CKD between the various regions and South Africa showed significant differences, except for one comparison between South Africa and an African study [p = 0.09 (95% CI - 0.04-0.01)]. Both sub-Saharan African studies had a higher prevalence than South Africa. One study in Africa had a higher prevalence, while the other had a lower prevalence, whilst one Global study had a higher prevalence, and the other had a lower prevalence compared to South Africa. The statistical differences analysed using the Cramer's V test were substantially less than 0.1. Thus, differences in comparisons were largely due to differences in sample sizes rather than actual differences. CONCLUSION: Variable prevalence rates between regions included disparities in sample size, definitions of CKD, lack of chronicity testing and heterogeneous laboratory estimations of eGFR. Improved consistency and enhanced methods for diagnosing and comparing CKD prevalence are essential.


Assuntos
Insuficiência Renal Crônica , Feminino , Humanos , Masculino , Prevalência , Insuficiência Renal Crônica/diagnóstico , Insuficiência Renal Crônica/epidemiologia , África do Sul/epidemiologia
2.
Kidney Int ; 98(5S): S117-S134, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33126957

RESUMO

There is a huge gap between the number of patients worldwide requiring versus those actually receiving safe, sustainable, and equitable care for kidney failure. To address this, the International Society of Nephrology coordinated the development of a Strategic Plan for Integrated Care of Patients with Kidney Failure. Implementation of the plan will require engagement of the whole kidney community over the next 5-10 years.


Assuntos
Prestação Integrada de Cuidados de Saúde , Nefrologia , Insuficiência Renal , Humanos
3.
Am J Kidney Dis ; 75(3): 404-412, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31955922

RESUMO

Outcomes reported in randomized controlled trials in peritoneal dialysis (PD) are diverse, are measured inconsistently, and may not be important to patients, families, and clinicians. The Standardized Outcomes in Nephrology-Peritoneal Dialysis (SONG-PD) initiative aims to establish a core outcome set for trials in PD based on the shared priorities of all stakeholders. We convened an international SONG-PD stakeholder consensus workshop in May 2018 in Vancouver, Canada. Nineteen patients/caregivers and 51 health professionals attended. Participants discussed core outcome domains and implementation in trials in PD. Four themes relating to the formation of core outcome domains were identified: life participation as a main goal of PD, impact of fatigue, empowerment for preparation and planning, and separation of contributing factors from core factors. Considerations for implementation were identified: standardizing patient-reported outcomes, requiring a validated and feasible measure, simplicity of binary outcomes, responsiveness to interventions, and using positive terminology. All stakeholders supported inclusion of PD-related infection, cardiovascular disease, mortality, technique survival, and life participation as the core outcome domains for PD.


Assuntos
Consenso , Nefrologia , Avaliação de Resultados em Cuidados de Saúde , Diálise Peritoneal/métodos , Técnica Delphi , Humanos , Projetos de Pesquisa
4.
Nephrol Dial Transplant ; 35(11): 1949-1958, 2020 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-32712672

RESUMO

BACKGROUND: While peritoneal dialysis (PD) can offer patients more independence and flexibility compared with in-center hemodialysis, managing the ongoing and technically demanding regimen can impose a burden on patients and caregivers. Patient empowerment can strengthen capacity for self-management and improve treatment outcomes. We aimed to describe patients' and caregivers' perspectives on the meaning and role of patient empowerment in PD. METHODS: Adult patients receiving PD (n = 81) and their caregivers (n = 45), purposively sampled from nine dialysis units in Australia, Hong Kong and the USA, participated in 14 focus groups. Transcripts were thematically analyzed. RESULTS: We identified six themes: lacking clarity for self-management (limited understanding of rationale behind necessary restrictions, muddled by conflicting information); PD regimen restricting flexibility and freedom (burden in budgeting time, confined to be close to home); strength with supportive relationships (gaining reassurance with practical assistance, comforted by considerate health professionals, supported by family and friends); defying constraints (reclaiming the day, undeterred by treatment, refusing to be defined by illness); regaining lost vitality (enabling physical functioning, restoring energy for life participation); and personal growth through adjustment (building resilience and enabling positive outlook, accepting the dialysis regimen). CONCLUSIONS: Understanding the rationale behind lifestyle restrictions, practical assistance and family support in managing PD promoted patient empowerment, whereas being constrained in time and capacity for life participation outside the home undermined it. Education, counseling and strategies to minimize the disruption and burden of PD may enhance satisfaction and outcomes in patients requiring PD.


Assuntos
Cuidadores/psicologia , Grupos Focais , Estilo de Vida , Participação do Paciente/métodos , Participação do Paciente/psicologia , Diálise Peritoneal/psicologia , Autogestão/psicologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Autogestão/métodos , Resultado do Tratamento , Adulto Jovem
5.
Clin Nephrol ; 93(1): 87-93, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31397267

RESUMO

Chronic kidney disease (CKD) is a frequent complication of HIV infection. The classic involvement of the kidney by HIV infection is HIV-associated nephropathy (HIVAN), occurring typically in young adults of African ancestry with advanced HIV disease in association with APOL1 high-risk variants. HIV-immune complex disease is histologically the second most common diagnosis. With the introduction of antiretroviral therapy (ART), there has been a decline in the incidence of HIVAN, with an increasing prevalence of focal segmental glomerulosclerosis. Several studies have demonstrated overall improvement in kidney function with initiation of ART. Many antiretroviral medications are partially or completely eliminated by the kidney and require dose adjustment in CKD. HIV-positive patients requiring either hemo- or peritoneal dialysis, who are stable on ART, are achieving survival rates comparable to those of dialysis patients without HIV infection. Kidney transplantation has been performed successfully in HIV-positive patients; graft and patient survival is similar to that of HIV-negative recipients. Early detection of kidney disease by implementation of screening on diagnosis of HIV infection and annual screening thereafter will have an impact on the burden of disease, together with access to ART. Programs for prevention of HIV infection are essential.


Assuntos
Nefropatia Associada a AIDS/terapia , Insuficiência Renal Crônica/terapia , Nefropatia Associada a AIDS/epidemiologia , Fármacos Anti-HIV/efeitos adversos , Fármacos Anti-HIV/uso terapêutico , Feminino , Humanos , Rim/efeitos dos fármacos , Transplante de Rim , Masculino , Diálise Renal , Insuficiência Renal Crônica/epidemiologia , Adulto Jovem
6.
Clin Nephrol ; 93(1): 82-86, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31426909

RESUMO

Inflammation is a major risk factor for atherosclerosis. Genetic polymorphisms in the inflammatory cytokine genes have been associated with atherosclerosis. Because levels of inflammatory cytokines are markedly elevated in patients with chronic kidney disease (CKD), we hypothesized that genotypic variations in the interleukin-6 (IL-6) gene are a cause of systemic inflammatory states and atherosclerosis in South African CKD patients. 120 CKD patients and 40 healthy controls were included. Serum IL-6 and high-sensitivity C-reactive protein (hs-CRP) levels were measured. Functional polymorphisms in the IL-6 genes were genotyped using polymerase chain reaction-sequence specific primer (PCR-SSP) methods. Carotid intima-media thickness (CIMT) and the presence of plaque were assessed by B-mode ultrasonography. Serum IL-6 and hs-CRP levels were increased in patients with CKD compared with healthy controls (p < 0.001). In CKD patients, serum IL-6 above the median value was associated with carotid plaque (OR: 2.11; 95% CI: 1.74 - 2.57, p = 0.004), with excess risk confined to the group with high IL-6 levels. Significant associations were found between the IL-6 gene and atherosclerosis in the CKD group (for G/G genotype: OR = 1.21, 95% CI = 1.05 - 1.39, p = 0.012; for GG+GC vs. CC: OR = 1.14, 95% CI = 1.02 - 1.28, p = 0.035). Patients with GG+GC genotype of the IL-6 gene polymorphism had higher levels of IL-6 than those with CC genotype (p = 0.029). In South African CKD patients, the IL-6 gene promoter polymorphism is associated with high serum IL-6 levels and atherosclerosis. The relationship between atherosclerosis and -174G/C polymorphism in the IL-6 gene suggests that IL-6 may be a potential pro-inflammatory mediator of atherosclerosis in CKD patients.


Assuntos
Aterosclerose/etiologia , Interleucina-6/genética , Polimorfismo Genético , Insuficiência Renal Crônica/complicações , Adulto , Proteína C-Reativa/análise , Feminino , Genótipo , Humanos , Interleucina-6/sangue , Masculino , Pessoa de Meia-Idade
7.
BMC Nephrol ; 21(1): 436, 2020 10 16.
Artigo em Inglês | MEDLINE | ID: mdl-33066744

RESUMO

BACKGROUND: Individuals of African descent are at higher risk of developing kidney disease than their European counterparts, and HIV infection is associated with increased risk of nephropathy. Despite a safe renal profile in the clinical trials, long-term use of tenofovir disoproxil fumarate (TDF) has been associated with proximal renal tubulopathy although the underlying mechanisms remain undetermined. We aim to establish the prevalence of and risk factors for TDF-induced kidney tubular dysfunction (KTD) among HIV-I and II individuals treated with TDF in south-west Nigeria. Association between TDF-induced KTD and genetic polymorphisms in renal drug transporter genes and the APOL1 (Apolipoprotein L1) gene will be examined. METHODS: This study has two phases. An initial cross-sectional study will screen 3000 individuals attending the HIV clinics in south-west Nigeria for KTD to determine the prevalence and risk factors. This will be followed by a case-control study of 400 KTD cases and 400 matched controls to evaluate single nucleotide polymorphism (SNP) associations. Data on socio-demographics, risk factors for kidney dysfunction and HIV history will be collected by questionnaire. Blood and urine samples for measurements of severity of HIV disease (CD4 count, viral load) and renal function (creatinine, eGFR, phosphate, uric acid, glucose) will also be collected. Utility of urinary retinol binding protein (RBP) and N-acetyl-beta-D-glucosaminidase (NAG) levels as surrogate markers of KTD will be evaluated. Genomic DNA will be extracted from whole blood and SNP analyses performed using the rhAMP SNP genotyping assays. Statistical analysis including univariate and multivariate logistic regression analyses will be performed to identify factors associated with KTD. DISCUSSION: In spite of TDF being the most commonly used antiretroviral agent and a key component of many HIV treatment regimens, it has potential detrimental effects on the kidneys. This study will establish the burden and risk factors for TDF-induced KTD in Nigerians, and explore associations between KTD and polymorphisms in renal transporter genes as well as APOL1 risk variants. This study may potentially engender an approach for prevention as well as stemming the burden of CKD in sub-Saharan Africa where GDP per capita is low and budgetary allocation for health is inadequate.


Assuntos
Fármacos Anti-HIV/efeitos adversos , Soropositividade para HIV/complicações , Nefropatias/induzido quimicamente , Túbulos Renais/efeitos dos fármacos , Polimorfismo de Nucleotídeo Único , Tenofovir/efeitos adversos , Adulto , Fármacos Anti-HIV/uso terapêutico , População Negra/genética , Estudos de Casos e Controles , Estudos Transversais , Feminino , Soropositividade para HIV/tratamento farmacológico , HIV-1 , HIV-2 , Humanos , Nefropatias/epidemiologia , Nefropatias/genética , Túbulos Renais/patologia , Túbulos Renais/fisiologia , Masculino , Nigéria/epidemiologia , Testes Farmacogenômicos , Prevalência , Projetos de Pesquisa , Fatores de Risco , Fatores Socioeconômicos , Tenofovir/uso terapêutico , Carga Viral
8.
BMC Nephrol ; 21(1): 415, 2020 09 29.
Artigo em Inglês | MEDLINE | ID: mdl-32993549

RESUMO

BACKGROUND: Anaemia is a common presenting feature among patients with chronic kidney disease (CKD) and it is associated with poor clinical outcomes and quality of life. It is not clear if growth differentiation factor-15 (GDF-15) or hepcidin are useful as early markers of iron deficiency anaemia (IDA) among non-dialysis CKD patients. We therefore evaluated the diagnostic validity of GDF-15 and hepcidin as biomarkers of IDA among non-dialysis CKD patients in Johannesburg, South Africa. METHOD: An analytic cross-sectional study was conducted among non-dialysis CKD patients (n = 312) and apparently healthy controls (n = 184) from June to December 2016 at an Academic Hospital, in Johannesburg, South Africa. An interviewer administered proforma was used to obtain the socio-biological and clinical characteristics of the participants. Serum levels of GDF-15 and hepcidin were determined. Predictive logistic regression models were built and post estimation receiver operator characteristics were determined to evaluate diagnostic validity of hepcidin and GDF-15 for absolute and functional iron deficiency anaemia. RESULTS: About half (50.6%) of the participants were female while the participants' mean age was 49.7 ± 15.8 years. The predictive value of diagnosing absolute IDA among CKD patients using GDF-15 was 74.02% (95% CI: 67.62-80.42%) while the predictive value of diagnosing functional IDA among CKD patients using hepcidin was 70.1% (95% CI: 62.79-77.49%).There was a weak negative correlation between hepcidin levels and GFR (r = - 0.19, p = 0.04) in anaemic CKD patients, and between serum GDF-15 and haemoglobin (r = - 0.34, p = 0.001). Serum ferritin (ß = 0.00389, P-value< 0.001), was a predictor of log hepcidin. MCHC (ß = - 0.0220, P-value 0.005) and CKD stage (ß = 0.4761, P-value < 0.001), race (ß = 0.3429, P-value = 0.018) were predictors of log GDF-15. Both GDF-15 (adj OR: 1.0003, 95%CI: 1.0001-1.0005, P = 0.017) and hepcidin (adj OR: 1.003, 95%CI: 1.0004-1.0055, P = 0.023) were associated with iron deficiency anaemia after multiple linear regression modelling. CONCLUSION: Serum GDF-15 is a potential biomarker of absolute IDA, while hepcidin levels can predict functional IDA among CKD patients.


Assuntos
Anemia Ferropriva/diagnóstico , Fator 15 de Diferenciação de Crescimento/sangue , Hepcidinas/sangue , Insuficiência Renal Crônica/sangue , Adulto , Anemia Ferropriva/sangue , Anemia Ferropriva/etiologia , Biomarcadores/sangue , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Curva ROC , Insuficiência Renal Crônica/complicações , África do Sul
9.
BMC Nephrol ; 21(1): 20, 2020 01 15.
Artigo em Inglês | MEDLINE | ID: mdl-31941441

RESUMO

BACKGROUND: Chronic kidney disease (CKD) is a substantial cause of morbidity and mortality worldwide with disproportionate effects in sub-Saharan Africa (SSA). The optimal methods to estimate glomerular filtration rate (GFR) and therefore to determine the presence of CKD in SSA are uncertain. We plan to measure iohexol excretion to accurately determine GFR in Malawi, South Africa and Uganda. We will then assess the performance of existing equations to estimate GFR and determine whether a modified equation can better improve estimation of GFR in sub-Saharan Africa. METHODS: The African Research on Kidney Disease (ARK) study is a three-country study embedded within existing cohorts. We seek to enrol 3000 adults > 18 years based on baseline serum creatinine. Study procedures include questionnaires on socio-demographics and established risk factors for kidney disease along with anthropometry, body composition, blood pressure, blood chemistry and urine microscopy and albuminuria. We will measure GFR (mGFR) by plasma clearance of iohexol at 120, 180 and 240 min. We will compare eGFR determined by established equations with mGFR using Bland-Altman plots. We will use regression methods to estimate GFR and compare the newly derived model with existing equations. DISCUSSION: Through the ARK study, we aim to establish the optimal approach to estimate GFR in SSA. The study has the advantage of drawing participants from three countries, which will increase the applicability of the findings across the region. It is also embedded within established cohorts that have longitudinal information and serial measures that can be used to characterize kidney disease over a period of time. This will help to overcome the limitations of previous research, including small numbers, selected population sub-groups, and lack of data on proteinuria. The ARK collaboration provides an opportunity for close working partnerships across different centres, using standardized protocols and measurements, and shared bio-repositories. We plan to build on the collaboration for this study for future work on kidney disease in sub-Saharan Africa, and welcome additional partners from across the continent.


Assuntos
Taxa de Filtração Glomerular , Iohexol/farmacocinética , Insuficiência Renal Crônica/diagnóstico , Insuficiência Renal Crônica/fisiopatologia , Adulto , África Subsaariana , Feminino , Humanos , Malaui , Masculino , Seleção de Pacientes , Garantia da Qualidade dos Cuidados de Saúde , Análise de Regressão , Projetos de Pesquisa , África do Sul , Uganda
11.
Kidney Int ; 96(3): 699-710, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31200941

RESUMO

Shared decision-making about clinical care options in end-stage kidney disease is limited by inconsistencies in the reporting of outcomes and the omission of patient-important outcomes in trials. Here we generated a consensus-based prioritized list of outcomes to be reported during trials in peritoneal dialysis (PD). In an international, online, three-round Delphi survey, patients/caregivers and health professionals rated the importance of outcomes using a 9-point Likert scale (with 7-9 indicating critical importance) and provided comments. Using a Best-Worst Scale (BWS), the relative importance of outcomes was estimated. Comments were analyzed thematically. In total, 873 participants (207 patients/caregivers and 666 health professionals) from 68 countries completed round one, 629 completed round two and 530 completed round three. The top outcomes were PD-related infection, membrane function, peritoneal dialysis failure, cardiovascular disease, death, catheter complications, and the ability to do usual activities. Compared with health professionals, patients/caregivers gave higher priority to six outcomes: blood pressure (mean difference, 0.4), fatigue (0.3), membrane function (0.3), impact on family/friends (0.1), peritoneal thickening (0.1) and usual activities (0.1). Four themes were identified that underpinned the reasons for ratings: contributing to treatment longevity, preserving quality of life, escalating morbidity, and irrelevant and futile information and treatment. Patients/caregivers and health professionals gave highest priority to clinical outcomes. In contrast to health professionals, patients/caregivers gave higher priority to lifestyle-related outcomes including the impact on family/friends and usual activities. Thus, prioritization will inform a core outcome set to improve the consistency and relevance of outcomes for trials in PD.


Assuntos
Consenso , Falência Renal Crônica/terapia , Avaliação de Resultados em Cuidados de Saúde/normas , Diálise Peritoneal/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como Assunto/normas , Adolescente , Adulto , Idoso , Tomada de Decisão Compartilhada , Técnica Delphi , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Qualidade de Vida , Inquéritos e Questionários , Adulto Jovem
12.
Clin Nephrol ; 91(1): 40-47, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30369398

RESUMO

Variants in apolipoprotein L1 (APOL1) gene were shown to be associated with higher rates of nondiabetic kidney disease in black patients compared with white patients. Frequencies of these variants differ substantially in African populations, suggesting that their contribution to kidney disease might differ. We determined the frequency and association of (APOL1) risk alleles with markers of kidney disease in black South Africans with hypertension-attributed chronic kidney disease (CKD) and their first-degree relatives. Black patients with hypertension-attributed CKD with an estimated glomerular filtration rate (eGFR) ≤ 60 mL/min/1.73m2 were included, together with their first-degree relatives. G1 (rs60910145 and rs73885319) and G2: rs71785313 single nucleotide polymorphisms were genotyped by restriction fragment length polymorphism. Similar to previous association studies, we mainly tested recessive genetic models. The allele frequencies of both the G1 and G2 (APOL1) risk alleles were similar amongst all the groups. There was no difference in the two-risk-allele frequency in CKD patients (10%) compared to controls (8.6%), p = 0.790. Carriage of two (APOL1) risk alleles (vs. zero or one risk allele) was not a predictor of hypertension-attributed CKD (OR, 0.85; 95% CI, 0.25 - 2.83; p = 0.790). Patients with CKD and first-degree relatives with and without (APOL1) risk alleles had statistically indistinguishable blood pressures, creatinine and HDL-cholesterol levels. Apolipoprotein L1 risk variants are present in black South Africans with similar frequencies between CKD patients, first-degree relatives, and healthy controls. The lack of association of these variants with hypertension-attributed CKD in this population needs to be explored further in studies with larger sample sizes.
.


Assuntos
Apolipoproteína L1/genética , Hipertensão Renal/genética , Nefrite/genética , Insuficiência Renal Crônica/genética , Adulto , Alelos , População Negra/genética , Estudos de Casos e Controles , Creatinina/sangue , Feminino , Frequência do Gene , Predisposição Genética para Doença , Variação Genética , Genótipo , Taxa de Filtração Glomerular , Humanos , Hipertensão Renal/etnologia , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Nefrite/etnologia , Polimorfismo de Nucleotídeo Único , Prevalência , Insuficiência Renal Crônica/etnologia , Insuficiência Renal Crônica/etiologia , Fatores de Risco , Adulto Jovem
13.
Kidney Int ; 93(3): 545-559, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29398134

RESUMO

HIV-positive individuals are at increased risk for kidney disease, including HIV-associated nephropathy, noncollapsing focal segmental glomerulosclerosis, immune-complex kidney disease, and comorbid kidney disease, as well as kidney injury resulting from prolonged exposure to antiretroviral therapy or from opportunistic infections. Clinical guidelines for kidney disease prevention and treatment in HIV-positive individuals are largely extrapolated from studies in the general population, and do not fully incorporate existing knowledge of the unique HIV-related pathways and genetic factors that contribute to the risk of kidney disease in this population. We convened an international panel of experts in nephrology, renal pathology, and infectious diseases to define the pathology of kidney disease in the setting of HIV infection; describe the role of genetics in the natural history, diagnosis, and treatment of kidney disease in HIV-positive individuals; characterize the renal risk-benefit of antiretroviral therapy for HIV treatment and prevention; and define best practices for the prevention and management of kidney disease in HIV-positive individuals.


Assuntos
Nefropatia Associada a AIDS , HIV , Rim , Nefrologia/normas , Insuficiência Renal Crônica , Nefropatia Associada a AIDS/diagnóstico , Nefropatia Associada a AIDS/epidemiologia , Nefropatia Associada a AIDS/genética , Nefropatia Associada a AIDS/terapia , Fármacos Anti-HIV/efeitos adversos , Comorbidade , Diagnóstico Diferencial , Medicina Baseada em Evidências/normas , Predisposição Genética para Doença , HIV/efeitos dos fármacos , HIV/genética , HIV/patogenicidade , Interações Hospedeiro-Patógeno , Humanos , Rim/efeitos dos fármacos , Rim/patologia , Rim/virologia , Valor Preditivo dos Testes , Insuficiência Renal Crônica/diagnóstico , Insuficiência Renal Crônica/epidemiologia , Insuficiência Renal Crônica/genética , Insuficiência Renal Crônica/terapia , Fatores de Risco , Resultado do Tratamento
14.
BMC Nephrol ; 19(1): 30, 2018 02 07.
Artigo em Inglês | MEDLINE | ID: mdl-29415666

RESUMO

BACKGROUND: It remains unclear whether genetic factors may explain the reported variation in the levels of biochemical markers of chronic kidney disease mineral and bone disorders (CKD- MBD) across ethnic groups. Therefore, the aim of this study was to examine the influence of vitamin D receptor (VDR) polymorphisms on secondary hyperparathyroidism and its association with vitamin D levels in black and white South African study participants. METHODS: This was a cross sectional study involving 272 CKD stage 3- 5D patients and 90 healthy controls. The four major VDR polymorphisms (Bsm 1, Fok 1, Taq 1, and Apa1) were genotyped using the polymerase chain reaction- restriction fragment length polymorphism (PCR -RFLP) method. In addition, biochemical markers of CKD-MBD were measured to determine their associations with the four VDR polymorphisms. RESULTS: With the exception of Taq I polymorphism, the distribution of the VDR polymorphisms differed significantly between blacks and whites. In hemodialysis patients, the Bb genotype was significantly associated with moderate secondary hyperparathyroidism (OR, 3.88; 95 CI 1.13-13.25, p = 0.03) and severe hyperparathyroidism (OR, 2.54; 95 CI 1.08-5.96, p = 0.03). This was consistent with the observed higher levels of median parathyroid hormone, fibroblast growth factor 23 and mean phosphate in patients with Bb genotype. This candidate risk genotype (Bb) was over represented in blacks compared to whites (71.0% versus 55.6%, p < 0.0001). In an unadjusted regression model, FokFf genotype was found to be significantly associated with the risk of developing severe vitamin D deficiency < 15 ng/ml (OR, 1.89; 95 CI 1.17-3.07, p = 0.01). CONCLUSION: The VDR Bb genotype is an independent predictor of developing secondary hyperparathyroidism in patients with end stage kidney disease. In addition, study participants with FokFf genotype are at increased of developing severe 25 -hydroxyvitamin D [25(OH)D] deficiency.


Assuntos
Densidade Óssea/genética , Hiperparatireoidismo/genética , Polimorfismo Genético/genética , Receptores de Calcitriol/genética , Insuficiência Renal Crônica/genética , Adulto , Idoso , Biomarcadores/sangue , Estudos Transversais , Feminino , Humanos , Hiperparatireoidismo/sangue , Hiperparatireoidismo/epidemiologia , Masculino , Pessoa de Meia-Idade , Receptores de Calcitriol/sangue , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/epidemiologia , África do Sul/epidemiologia
15.
Clin Nephrol ; 86 (2016)(13): 84-89, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27469153

RESUMO

Chronic kidney disease (CKD), a major public health problem, is especially challenging for patients and healthcare personnel in Africa, a region with poor economic resources and a massive shortage of health-care workers. The burden of kidney disease is increased in poorly-resourced regions due to increased exposure to infections, poverty, poor access to healthcare, and genetic predisposition to kidney disease, contributing further to the problems when managing CKD and acute kidney injury. The vast majority of patients do not have access to renal replacement therapy. Urgent attention to cost of dialysis is required for wider expansion of services so that renal replacement therapy is affordable for the governments and populations of Africa. Priority needs to be given to prevention and treatment of acute kidney injury. Lack of resources has hampered the widespread utilization of prevention strategies; these are optimally delivered in a primary healthcare setting by doctors, nurses, and other healthcare workers with access to protocols for screening, disease management, achievement of treatment goals (with availability of therapy to retard progression), and criteria for referral to specialist and nephrology expertise. A regional or national renal registry is an important initiative to obtain accurate data on the burden of disease and outcomes of therapeutic interventions.


Assuntos
Recursos em Saúde , Nefrologia/tendências , Prática Profissional/tendências , Injúria Renal Aguda/terapia , África , Humanos , Encaminhamento e Consulta , Insuficiência Renal Crônica/terapia , Terapia de Substituição Renal/tendências
16.
Clin Nephrol ; 86 (2016)(13): 131-135, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27509588

RESUMO

BACKGROUND: Fluid overload is common in chronic kidney disease (CKD) patients, potentially driving chronic inflammation and left ventricular dysfunction. We investigated the association between volume overload, chronic inflammation, and left ventricular dysfunction across subgroups of CKD patients. METHODS: The study included 160 participants, comprising peritoneal dialysis (PD), hemodialysis (HD), stage-3 CKD patients, and age- and sex-matched controls (40 in each group). Fluid status was assessed using a body composition monitor (BCM); serum endotoxin, lipopolysaccharide binding protein (LBP), C-reactive protein (CRP). and interleukin-6 (IL-6) levels were measured as markers of inflammation. Echocardiography was done to assess left ventricular dimension and function. RESULTS: Endotoxemia and volume overload were common across the spectrum of CKD patients and were aggravated by worsening kidney function. Among HD cohorts, postdialysis endotoxemia was increased among patients with dialysis-induced hemodynamic instability and was also closely related to ultrafiltration volume. Endotoxin, IL-6, CRP, and LBP levels were elevated in patients with volume overload compared to euvolemic patients (p < 0.05). Patients with elevated circulating endotoxemia had higher left ventricular mass index (LVMI) compared to patients with lower endotoxin levels. Fluid overload correlated with endotoxin levels, IL-6, and LVMI; while LVMI correlated weakly with LBP and CRP. CONCLUSION: CKD patients typically presented with significant endotoxemia and overt volume overload, which may contribute significantly to chronic low-grade inflammation and left ventricular dysfunction. An additive contribution from hemodialysis treatment may strongly enhance the severity of endotoxemia in HD patients.


Assuntos
Volume Cardíaco/fisiologia , Insuficiência Renal Crônica/fisiopatologia , Disfunção Ventricular Esquerda/fisiopatologia , Proteínas de Fase Aguda , Adulto , Biomarcadores/sangue , Composição Corporal/fisiologia , Proteína C-Reativa/análise , Proteínas de Transporte/sangue , Estudos de Casos e Controles , Estudos de Coortes , Estudos Transversais , Ecocardiografia/métodos , Edema/fisiopatologia , Endotoxinas/sangue , Líquido Extracelular/metabolismo , Humanos , Inflamação , Interleucina-6/sangue , Falência Renal Crônica/fisiopatologia , Glicoproteínas de Membrana/sangue , Pessoa de Meia-Idade , Diálise Peritoneal/métodos , Diálise Renal/métodos , Insuficiência Renal Crônica/diagnóstico por imagem , Insuficiência Renal Crônica/terapia , Disfunção Ventricular Esquerda/diagnóstico por imagem
17.
Clin Nephrol ; 86(7): 27-34, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27285312

RESUMO

BACKGROUND: Fluid retention occurs early in chronic kidney disease (CKD) resulting in increased cardiovascular morbidity and mortality. This study aimed to assess volume and nutritional status among South African CKD participants and determine the relationship between malnutrition, inflammation, atherosclerosis, and volume overload using a body composition monitor (BCM). We also evaluated the usefulness of BCM measurement in assessing volume overload. METHODS: 160 participants comprising hemodialysis, peritoneal dialysis, stage 3 CKD patients, and healthy controls (40 in each group) were studied. A BCM was used to assess fluid and nutritional status. Cardiac dimension measurements, and inferior vena cava diameter (IVCD) and carotid intima media thickness were assessed by echocardiography and ultrasonography, respectively. Serum interleukin-6 (IL-6) and C-reactive protein (CRP) levels were measured as markers of inflammation. RESULTS: Fluid overload and malnutrition were present in 68% and 63% of studied patients, respectively. Using physical examination findings as the reference measurements for volume overload, the area under the concentration curves for BCM and IVCD measurements were 0.866 (sensitivity 82%, specificity 74%, p < 0.001) and 0.727 (sensitivity 57%, specificity 70%, p < 0.001), respectively. Lean tissue index, inflammation, and atherosclerosis were associated with volume overload. CONCLUSIONS: Volume overload and malnutrition were common across the spectrum of South African CKD cohorts; volume overload was associated with malnutrition, inflammation, and atherosclerosis. Bioimpedance spectroscopy (BIS) is a useful and sensitive tool for the assessment of fluid status in clinically euvolumic nondialytic CKD patients.


Assuntos
Desnutrição/diagnóstico , Diálise Renal/efeitos adversos , Insuficiência Renal Crônica/terapia , Veia Cava Inferior/diagnóstico por imagem , Desequilíbrio Hidroeletrolítico , Adulto , Aterosclerose/complicações , Aterosclerose/etiologia , Biomarcadores/sangue , Proteína C-Reativa/metabolismo , Espessura Intima-Media Carotídea , Ecocardiografia , Impedância Elétrica , Feminino , Coração/diagnóstico por imagem , Humanos , Inflamação/sangue , Inflamação/etiologia , Interleucina-6/sangue , Masculino , Pessoa de Meia-Idade , Estado Nutricional , Diálise Peritoneal/efeitos adversos , Insuficiência Renal Crônica/complicações , Fatores de Risco , África do Sul , Análise Espectral
18.
J Am Soc Nephrol ; 26(11): 2882-90, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25788523

RESUMO

APOL1 variants are associated with HIV-associated nephropathy and FSGS in African Americans. The prevalence of these variants in African populations with CKD in HIV-1 infection has not been investigated. We determined the role of APOL1 variants in 120 patients with HIV-associated nephropathy and CKD and 108 controls from a South-African black population. Patients with CKD were selected on the basis of histology. Genotypes were successfully determined for APOL1 G1 and G2 variants and 42 single nucleotide polymorphisms, including 18 ancestry informative markers, for 116 patients with CKD (96.7%; 38 patients with HIV-associated nephropathy, 39 patients with HIV-positive CKD, and 39 patients with HIV-negative CKD), and 108 controls (100%). Overall, 79% of patients with HIV-associated nephropathy and 2% of population controls carried two risk alleles. In a recessive model, individuals carrying any combination of two APOL1 risk alleles had 89-fold higher odds (95% confidence interval, 18 to 912; P<0.001) of developing HIV-associated nephropathy compared with HIV-positive controls. Population allele frequencies were 7.3% for G1 and 11.1% for G2. APOL1 risk alleles were not significantly associated with other forms of CKD. These results indicate HIV-positive, antiretroviral therapy-naïve South-African blacks with two APOL1 risk alleles are at very high risk for developing HIV-associated nephropathy. Further studies are required to determine the effect of APOL1 risk variants on kidney diseases in other regions of sub-Saharan Africa.


Assuntos
Nefropatia Associada a AIDS/sangue , Nefropatia Associada a AIDS/genética , Apolipoproteínas/sangue , Apolipoproteínas/genética , Lipoproteínas HDL/sangue , Lipoproteínas HDL/genética , Polimorfismo de Nucleotídeo Único , Nefropatia Associada a AIDS/etnologia , Adulto , Alelos , Apolipoproteína L1 , População Negra , Feminino , Frequência do Gene , Predisposição Genética para Doença , Variação Genética , Genótipo , Taxa de Filtração Glomerular , Haplótipos , Humanos , Inflamação , Desequilíbrio de Ligação , Masculino , Razão de Chances , Fenótipo , Prevalência , Fatores de Risco , África do Sul
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa